ArticleCancer cell international2021

Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma.

Yeong-Chin Jou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.